NDC 69800-6503-02 - BIVIGAM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69800-6503
- Requested NDC
- 69800-6503-02
- Package NDCs from labels
- 69800-6503-2, 69800-6503-1, 69800-6503-02
- Manufacturer
- ADMA Biologics, Inc.
- Effective date
- 2026-09-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BIVIGAM - ADMA Biologics, Inc. | ADMA Biologics, Inc. | 2026-09-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69800-6503-1 | BIVIGAM | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 15 | |
| 69800-6503-2 | BIVIGAM | 100 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 100 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69800-6503 | BIVIGAM (IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%) INJECTION, SOLUTION [ADMA BIOLOGICS, INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20250507_a2244aa0-a6d0-11df-b385-0002a5d5c51b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69800-6503-1 | ML - Milliliter | 69800-6503 | 5387ecb8-c0af-4240-9a1d-82e17815ec50 | 1 | 2021-09-07 |
| 69800-6503-2 | ML - Milliliter | 69800-6503 | cea45d7d-27ae-4856-8ae5-523e0f8d60bf | 1 | 2021-09-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ASCENIV | HUMAN IMMUNOGLOBULIN G | ADMA Biologics, Inc. | d74f4360-3b51-496c-96fb-84c3976958d2 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| QIVIGY kthm | HUMAN IMMUNOGLOBULIN G | Kedrion S.p.A. | 6f1933e0-240f-48f4-b246-8a30e63a4160 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| BIVIGAM | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% | ADMA Biologics, Inc. | a2244aa0-a6d0-11df-b385-0002a5d5c51b | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | BLA125389 69800-6503-2 69800-6502-1 69800-6503-1 69800-6502-2 69800-6502 69800-6503 69800650302 1809422 1809416 1809421 1809414 3469d327-8d5d-fff5-e063-6394a90a2cf2 a2244aa0-a6d0-11df-b385-0002a5d5c51b 66Y330CJHS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.